These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37507468)

  • 1. Suppression of VEGF and inflammatory cytokines, modulation of Annexin A1 and organ functions by galloylquinic acids in breast cancer model.
    Abd El-Salam M; El-Tanbouly G; Bastos J; Metwaly H
    Sci Rep; 2023 Jul; 13(1):12268. PubMed ID: 37507468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel antitumor activity of the combined treatment of galloylquinic acid compounds with doxorubicin in solid Ehrlich carcinoma model via the Notch signaling pathway modulation.
    Abd El-Salam MA; El-Tanbouly GS; Bastos JK; Metwaly HA
    Life Sci; 2022 Jun; 299():120497. PubMed ID: 35339508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synergistic effect between vanillin and doxorubicin in ehrlich ascites carcinoma solid tumor and MCF-7 human breast cancer cell line.
    Elsherbiny NM; Younis NN; Shaheen MA; Elseweidy MM
    Pathol Res Pract; 2016 Sep; 212(9):767-77. PubMed ID: 27493101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: A mechanistic insight.
    Rai G; Mishra S; Suman S; Shukla Y
    Phytomedicine; 2016 Mar; 23(3):233-42. PubMed ID: 26969377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin and folic acid-loaded zinc oxide nanoparticles-based combined anti-tumor and anti-inflammatory approach for enhanced anti-cancer therapy.
    Gomaa S; Nassef M; Tabl G; Zaki S; Abdel-Ghany A
    BMC Cancer; 2024 Jan; 24(1):34. PubMed ID: 38178054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic and antitumor effects of brucine on Ehrlich ascites tumor and human cancer cell line.
    Agrawal SS; Saraswati S; Mathur R; Pandey M
    Life Sci; 2011 Aug; 89(5-6):147-58. PubMed ID: 21684292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursolic acid inhibits tumor angiogenesis and induces apoptosis through mitochondrial-dependent pathway in Ehrlich ascites carcinoma tumor.
    Saraswati S; Agrawal SS; Alhaider AA
    Chem Biol Interact; 2013 Nov; 206(2):153-65. PubMed ID: 24051192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced antitumour activity of doxorubicin and simvastatin combination loaded nanoemulsion treatment against a Swiss albino mouse model of Ehrlich ascites carcinoma.
    Alkreathy HM; Alkhatib MH; Al Musaddi SA; Balamash KSA; Osman NN; Ahmad A
    Clin Exp Pharmacol Physiol; 2019 May; 46(5):496-505. PubMed ID: 30724380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antitumor effects of tetrodotoxin and/or doxorubicin on Ehrlich ascites carcinoma-bearing female mice.
    El-Dayem SM; Fouda FM; Ali EH; Motelp BA
    Toxicol Ind Health; 2013 Jun; 29(5):404-17. PubMed ID: 22317827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
    Ganguly A; Chakraborty P; Banerjee K; Chatterjee S; Basu S; Sarkar A; Chatterjee M; Choudhuri SK
    Biometals; 2012 Feb; 25(1):149-63. PubMed ID: 21915630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer Effects of New Ceramides Isolated from the Red Sea Red Algae
    Elhady SS; Habib ES; Abdelhameed RFA; Goda MS; Hazem RM; Mehanna ET; Helal MA; Hosny KM; Diri RM; Hassanean HA; Ibrahim AK; Eltamany EE; Abdelmohsen UR; Ahmed SA
    Mar Drugs; 2022 Jan; 20(1):. PubMed ID: 35049918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
    Majumder S; Dutta P; Mookerjee A; Choudhuri SK
    Chem Biol Interact; 2006 Feb; 159(2):90-103. PubMed ID: 16289015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-glycosyl Flavone from Urginea indica Inhibits Growth and Dissemination of Ehrlich Ascites Carcinoma Cells in Mice.
    Bevara GB; Kumar ADN; Koteswramma K L; Badana AK; Kumari S; Yarla NS; Malla RR
    Anticancer Agents Med Chem; 2017; 17(9):1256-1266. PubMed ID: 28044935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polydatin gold nanoparticles potentiate antitumor effect of doxorubicin in Ehrlich ascites carcinoma-bearing mice.
    Samra YA; Abdelghany AM; Zaghloul RA
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22869. PubMed ID: 34339076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hesperidin on mice bearing Ehrlich solid carcinoma maintained on doxorubicin.
    Khedr NF; Khalil RM
    Tumour Biol; 2015 Dec; 36(12):9267-75. PubMed ID: 26099723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
    Ray L; Kumar P; Gupta KC
    Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuftsin-Bearing Liposomes Co-Encapsulated with Doxorubicin and Curcumin Efficiently Inhibit EAC Tumor Growth in Mice.
    Murugesan K; Srinivasan P; Mahadeva R; Gupta CM; Haq W
    Int J Nanomedicine; 2020; 15():10547-10559. PubMed ID: 33414637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ponatinib/gossypol novel combination provides enhanced anticancer activity against murine solid Ehrlich carcinoma via triggering apoptosis and inhibiting proliferation/angiogenesis.
    El-Lakkany NM; Elkattan HH; Elsisi AE
    Toxicol Appl Pharmacol; 2021 Dec; 432():115767. PubMed ID: 34699866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis.
    Mookerjee A; Mookerjee Basu J; Dutta P; Majumder S; Bhattacharyya S; Biswas J; Pal S; Mukherjee P; Raha S; Baral RN; Das T; Efferth T; Sa G; Roy S; Choudhuri SK
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4339-49. PubMed ID: 16857809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo.
    Mookerjee A; Basu JM; Majumder S; Chatterjee S; Panda GS; Dutta P; Pal S; Mukherjee P; Efferth T; Roy S; Choudhuri SK
    BMC Cancer; 2006 Nov; 6():267. PubMed ID: 17107616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.